We also expect that massive sequencing of BARD1 in breast, ovarian cancers, neuroblastoma and other tumors will increase the number of rare pathogenic missense mutations to be inserted into the ClinVar database as “Pathogenic”. The gene discussed is BARD1; the disease is ovarian carcinoma.